On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine production in Africa on its planned schedule in Kigali, Rwanda, with a target for the first set of manufacturing BioNTainers to be delivered to the site by the end of 2022.

The company expects to set up additional factories in Senegal and South Africa in close coordination with its partners in the respective countries.